In ₹ Crore except Per Share Latest Annual | NEULANDLAB FY26 | DIVISLAB FY26 | LAURUSLABS FY26 | NH FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 83.89× | 97.31× | 117.94× | ◆ 47.97× | 97.31× -14% | |
| P/B | 16.38× | 14.89× | 19.31× | ◆ 8.57× | 14.89× +10% | |
| EV/EBITDA | 53.65× | 72.47× | 60.27× | ◆ 26.33× | 60.27× -11% | |
| Market Cap | ₹30,703 Cr | ₹2.49L Cr | ₹1.05L Cr | ₹38,888 Cr | ₹1.05L Cr -71% | |
| Growth | ||||||
| Revenue CAGR 3Y | 19.31% | 10.78% | 4.09% | ◆ 20.39% | 10.78% +79% | |
| Revenue CAGR 5Y | 16.64% | 8.67% | 7.19% | ◆ 25.05% | 8.67% +92% | |
| Net Income CAGR 3Y | ◆ 30.57% | 12.09% | 3.91% | 9.94% | 9.94% +208% | |
| Revenue YoY (latest Q) | ◆ 119.15% | 27.80% | 29.10% | 78.05% | 29.10% +309% | |
| Net Income YoY (latest Q) | ◆ 962.40% | 65.50% | 123.94% | 5.37% | 65.50% +1369% | |
| Profitability | ||||||
| EBITDA Margin | 28.40% | ◆ 32.59% | 26.09% | 20.47% | 26.09% +9% | |
| Net Income Margin | 17.99% | ◆ 24.32% | 13.07% | 10.21% | 13.07% +38% | |
| Return on Common Equity | ◆ 19.42% | 15.32% | 16.36% | 17.75% | 16.36% +19% | |
| Return on Capital Employed | ◆ 21.75% | 16.55% | 18.87% | 10.98% | 16.55% +31% | |
| Return on Assets | 12.42% | ◆ 12.82% | 8.47% | 6.46% | 8.47% +47% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.10× | ◆ 0.00× | 0.44× | 1.07× | 0.44× -77% | |
| Interest Coverage | 20.16× | ◆ 129.48× | 7.60× | 4.80× | 7.60× +165% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,023 Cr | ₹10,560 Cr | ₹6,813 Cr | ₹7,896 Cr | ₹7,896 Cr -74% | |
| Net Income | ₹364 Cr | ₹2,568 Cr | ₹890 Cr | ₹806 Cr | ₹890 Cr -59% | |
| Total Assets | ₹2,930 Cr | ₹20,033 Cr | ₹10,511 Cr | ₹12,474 Cr | ₹12,474 Cr -77% | |
| EPS | ₹283.71 | ₹96.75 | ₹16.47 | ₹39.67 | ₹39.67 +615% | |
| Book Value per Share | ₹1,453.02 | ₹632.49 | ₹100.61 | ₹222.13 | ₹222.13 +554% | |